Literature DB >> 14638715

Latanoprost stimulates secretion of matrix metalloproteinases in tenon fibroblasts both in vitro and in vivo.

Holger Mietz1, Johannes M Esser, Gerhard Welsandt, Norbert Kociok, Arno Hueber, Antonia Joussen, Peter Esser, Günter K Krieglstein.   

Abstract

PURPOSE: To investigate the presence and the possible role of different matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in Tenon capsule fibroblasts. These enzymes are essential for the control of tissue remodeling in the context of wound repair. This aspect is important to further the understanding of and possibly to influence the scarring process of filtering blebs after glaucoma surgery.
METHODS: Untreated and latanoprost-treated human Tenon fibroblasts were examined for the presence of MMPs and TIMPs on the mRNA and protein levels. Assays performed included RT-PCR, real-time RT-PCR, immunocytochemistry, Western blot analysis, flow cytometry, and zymography. To investigate the changes in vivo, conjunctival specimens of rabbits treated with latanoprost eye drops were examined by immunohistochemistry.
RESULTS: In all assays, both MMP-3 and TIMP-2 were detected. With the real-time RT-PCR technique, MMP-1, -2, -3, -7, -9, and -14 and TIMP-1 and -2 were detected. An upregulation of MMP-3 and TIMP-2 after latanoprost treatment of the fibroblasts was shown and found to occur on the mRNA and the protein levels. The upregulation of MMP-3 and TIMP-2 was confirmed in vivo.
CONCLUSIONS: Tenon fibroblasts contain the ability on the mRNA level to synthesize all enzymes of the MMP and TIMP family that are related to remodeling of the extracellular matrix. The levels of MMP-3 and TIMP-2 increase after treatment with latanoprost. Tenon fibroblasts may be the target cells for attempts to influence the tissue levels of MMPs and TIMPs in the context of conjunctival wound healing after glaucoma surgery.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14638715     DOI: 10.1167/iovs.02-0462

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  16 in total

Review 1.  Effects of common topical antiglaucoma medications on the ocular surface, eyelids and periorbital tissue.

Authors:  J Javier Servat; C Robert Bernardino
Journal:  Drugs Aging       Date:  2011-04-01       Impact factor: 3.923

2.  A case of keratoconus progression associated with the use of topical latanoprost.

Authors:  Shiro Amano; Yoshiyuki Nakai; Akiko Ko; Kenji Inoue; Masato Wakakura
Journal:  Jpn J Ophthalmol       Date:  2008-09-05       Impact factor: 2.447

3.  Effect of additive preoperative latanoprost treatment on the outcome of filtration surgery.

Authors:  Silke Berthold; Norbert Pfeiffer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-12-08       Impact factor: 3.117

4.  Elevated aqueous humour tissue inhibitor of matrix metalloproteinase-1 and connective tissue growth factor in pseudoexfoliation syndrome.

Authors:  S L Ho; G F Dogar; J Wang; J Crean; Q D Wu; N Oliver; S Weitz; A Murray; P E Cleary; C O'Brien
Journal:  Br J Ophthalmol       Date:  2005-02       Impact factor: 4.638

5.  Effect of topical prostaglandins on the biomechanics and shape of the cornea.

Authors:  Shiro Amano; Ryohei Nejima; Kenji Inoue; Kazunori Miyata
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-08-10       Impact factor: 3.117

6.  A sequential, multiple-treatment, targeted approach to reduce wound healing and failure of glaucoma filtration surgery in a rabbit model (an American Ophthalmological Society thesis).

Authors:  Mark Brian Sherwood
Journal:  Trans Am Ophthalmol Soc       Date:  2006

7.  High mobility group box 1 potentiates the pro-inflammatory effects of interleukin-1β in osteoarthritic synoviocytes.

Authors:  Isabel García-Arnandis; Maria Isabel Guillén; Francisco Gomar; Jean-Pierre Pelletier; Johanne Martel-Pelletier; Maria José Alcaraz
Journal:  Arthritis Res Ther       Date:  2010-08-27       Impact factor: 5.156

8.  Control of cell migration and inflammatory mediators production by CORM-2 in osteoarthritic synoviocytes.

Authors:  Isabel García-Arnandis; Maria Isabel Guillén; Francisco Gomar; Miguel Angel Castejón; Maria José Alcaraz
Journal:  PLoS One       Date:  2011-09-22       Impact factor: 3.240

9.  Brimonidine reduces TGF-beta-induced extracellular matrix synthesis in human Tenon's fibroblasts.

Authors:  Samin Hong; Sueng-Han Han; Chan Yun Kim; Kang Yoon Kim; Yoo Kyung Song; Gong Je Seong
Journal:  BMC Ophthalmol       Date:  2015-05-28       Impact factor: 2.209

10.  Ocular surface evaluation in patients treated with a fixed combination of prostaglandin analogues with 0.5% timolol maleate topical monotherapy: a randomized clinical trial.

Authors:  Heloisa Helena Russ; Pedro Antônio Nogueira-Filho; Jeison de Nadai Barros; Nubia Vanessa Lima de Faria; Fabiano Montiani-Ferreira; José Álvaro Pereira Gomes; Paulo Augusto Arruda Mello
Journal:  Clinics (Sao Paulo)       Date:  2013-10       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.